L-Cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity
- 1 January 1991
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 28 (3) , 166-170
- https://doi.org/10.1007/bf00685504
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Injurious effect of buthionine sulfoximine, an inhibitor of glutathione biosynthesis, on the lethality and urotoxicity of cyclophosphamide in mice.The Japanese Journal of Pharmacology, 1989
- Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamideCancer, 1988
- Prediction of Ifosfamide/Mesna associated encephalopathyEuropean Journal of Cancer and Clinical Oncology, 1986
- Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclophosphamide-induced urotoxicityCancer Letters, 1986
- HYPERSENSITIVITY TO MESNAThe Lancet, 1985
- Mutagenicity of Glutathione and Cysteine in the Ames TestScience, 1983
- Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna)European Journal of Cancer and Clinical Oncology, 1982
- Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention—IPublished by Elsevier ,1981
- Morphological changes in rat brain induced byl-cysteine injection in newborn animalsBrain Research, 1981
- THE REDUCTION IN VITRO IN VISCOSITY OF MUCOPROTEIN SOLUTIONS BY A NEW MUCOLYTIC AGENT, N‐ACETYL‐L‐CYSTEINEAnnals of the New York Academy of Sciences, 1963